BVT Bonus Zert CEC 31.12.2024/ DE000VD0JK85 /
12/06/2024 10:13:24 | Chg.+0.020 | Bid13:05:02 | Ask13:05:02 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
2.610EUR | +0.77% | 2.610 Bid Size: 31,000 |
2.650 Ask Size: 31,000 |
CECONOMY AG INH O.N... | - EUR | 31/12/2024 | Call |
GlobeNewswire
13:05
Clearside Biomedical’s Leadership in Suprachoroidal Delivery Featured in Multiple Presentations at t...
GlobeNewswire
13:03
Velocity Clinical Research partners with Luminis Health, moves into oncology in the U.S.
GlobeNewswire
13:00
Taysha Gene Therapies to Present Clinical Data from Both REVEAL Phase 1/2 Trials During Company-Host...
GlobeNewswire
13:00
Athira to Host Webinar Highlighting Potential for Fosgonimeton to Protect and Preserve Neuronal Heal...
GlobeNewswire
13:00
United Lithium Announces Drill Results for Lithium Pegmatites D & E Confirming Strike Length of over...
GlobeNewswire
13:00
Dorman Products announces the grand opening of an additional USA-based drive shaft manufacturing fac...
GlobeNewswire
13:00
Ero Copper's Tucumã Project Awarded Operational License - Commissioning On Track for First Copper Pr...
GlobeNewswire
13:00
Dianthus Therapeutics Announces FDA Clearance to Initiate Phase 2 Trial of DNTH103 in Multifocal Mot...
GlobeNewswire
13:00
Embrace the Spirit of Summer and Create Shareable Moments with Good Supply Cannabis
GlobeNewswire
13:00
2024 Report: LGBTQ+ Advertising Influential Over Brand Perceptions & Purchase Decisions
GlobeNewswire
13:00
KSQ Therapeutics Announces First Patient Dosed in Clinical Development Program for KSQ-001EX, a CRIS...
GlobeNewswire
13:00
Bread Financial™ Signs Long-Term Agreement to Provide Dual Credit Card Program for Saks Fifth Avenue...
GlobeNewswire
13:00
NodThera’s NLRP3 Inhibitor NT-0796 Meets Primary Endpoint of Inflammation Reversal in Phase Ib/IIa T...
GlobeNewswire
12:58
RentRedi and Home Title Lock Partner to Protect Rental Property Owners from Deed Fraud and Title The...